By Mary de Wet Iovance Biotherapeutics shares rose 15% in after-hours trade Friday after the company’s biologics license application for lifileucel to treat advanced...
Overview NVIDIA’s (NASDAQ:NVDA) latest earnings report might have been the biggest event in the stock market this year. Smashing expectations as well as issuing...
Cash-strapped landlords with maturing property debt aren’t being scared off by 12%-16% rates of interest, said Ben Miller, CEO of Fundrise, which recently launched...